Novel and Highly Potent ATR Inhibitor M4344 Kills Cancer Cells With Replication Stress, and Enhances the Chemotherapeutic Activity of Widely Used DNA Damaging Agents
Ukhyun Jo(Center for Cancer Research), Yves Pommier(National Institutes of Health)
Cited by 110
Related Papers
Human topoisomerases and their roles in genome stability and organization
|Nature Reviews Molecular Cell Biology|2022|446
Resistance to PARP inhibitors by SLFN11 inactivation can be overcome by ATR inhibition
|Oncotarget|2016|292
Inhibition of Histone Deacetylase in Cancer Cells Slows Down Replication Forks, Activates Dormant Origins, and Induces DNA Damage
|Cancer Research|2010|155
Optimal function of the DNA repair enzyme TDP1 requires its phosphorylation by ATM and/or DNA‐PK
|The EMBO Journal|2009|147
DNA cleavage assay for the identification of topoisomerase I inhibitors
|Nature Protocols|2008|106